GYREのPER（株価収益率）は？

Gyre Therapeutics Inc.（GYRE）は現在PER 168.11倍で取引されています。

GYREのROE（自己資本利益率）は？

Gyre Therapeutics Inc.のROEは-6.21%です。

GYREの配当利回りは？

Gyre Therapeutics Inc.の配当利回りは0.00%です。

GYREの品質スコア（Quality Score）は？

当社のAIはGYREの総合財務品質を100点中15点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

GYREは今が買い時ですか？

当社AIのタイミングスコアは100点中27点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

GYREはどのセクターに属しますか？

Gyre Therapeutics Inc.はHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）

GYRE (NASDAQ) 株価分析 | GYRE THERAPEUTICS INC.

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-04 | FS: 2026-03-31)

GYRE AI Analysis Summary

Our AI summary for GYRE: Gyre Therapeutics Inc. (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 168.11, ROE of -6.21%, a dividend yield of 0.00%. Its financial Quality Score stands at 15/100 — fundamentals below the market average. The AI Timing Score is 27/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

GYRE

Gyre Therapeutics Inc.

US:NASDAQ STOCK Healthcare >> Biotechnology News 97

USD 6.15

0.04 (0.65%) Day Change

Watchlist Portfolio Compare Chart

168.11

P/E

0.01

D/E

-6.2%

ROE

-3.9%

ROA

0.00%

Div Yield

-0.10

PEG

GYRE THERAPEUTICS INC.
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 6.15 Price 0.04 (0.65%) Day Change	NEWS SCORE: 97

GYRE, ファンダメンタルスコアはnot good ( ファンダメンタル = 15) そしてテクニカルスコアは ...(Sign In to See)...

Loading chart...

15 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: P/Eが高い。割高銘柄。
ROEが低い
ROAが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
ROAがROEに比べて低い
ROAの伸びが低い
Last-year ROA is lower than last-2-years ROA.
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not quite good , financial health is not good , and ability to make profit is not quite good , ...

Deepscope 分析

50%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	97
Magic Formula Rank by ROA	2798
Magic Formula Rank by ROE	2798
Magic Formula Rank by ROIC	2166
Price	6.15
PBV / Sector	4.97 / 44,022.72
Earning Per Share	-0.06

PE / Sector	168.11 / 19.17
PEG or PE/Growth / Sector	-0.10 / 1.24
Average 1M Daily Value	0.35 M GREAT
Average 1W Daily Value	0.32 M GREAT

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

52%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-5.37 / 98.24
NPM Average (%) / Sector	-13.86 / -1,697.63
NPM Change Average (%) / Sector	-1,035.18 / 5,097.97
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-3.88 / 185,260.96
ROA Average (%) / Sector	-13.65 / 36,684.70
ROA Change Average (%) / Sector	-861.22 / 422,221.66
ROE (%) / Sector	-6.21 / 243,762.23
ROE Average (%) / Sector	122.04 / 48,758.47 GREAT
ROE Change Average (%) / Sector	2,585.69 / 424,968.10 GOOD
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

41%

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	224.93 / 17.04 GREAT
Dividend Change Average (%) / Sector	-96.78 / -0.49

登録情報

Analyze Date	2026-08-05 08:00:18
Symbol	GYRE
Name	GYRE THERAPEUTICS INC.
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	111.49 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	681.20 / 9,586.08

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 12730 High Bluff Drive, San Diego, CA, United States, 92130

Phone: 858-284-0115

Website: https://www.gyretx.com

Employees: 625

Sector: Healthcare >> Biotechnology

Description: Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis. The company offers ETUARY (Pirfenidone), an anti-fibrotic drug approved for the treatment of idiopathic pulmonary fibrosis; and under Phase 3 trials for the treatment of pneumoconiosis. It is also involved in the development of F351 (Hydronidone), a structural derivative of ETUARY under Phase 3 trials for the treatment of chronic hepatitis B (CHB)-associated liver fibrosis; and completed Phase 1 trials for the treatment of liver fibrosis associated with metabolic dysfunction-associated steatohepatitis. In addition, the company develops F573, which is in Phase 2 clinical trials for the treatment of acute/acute-on-chronic liver failure. Further, its preclinical products include F230 for the treatment of pulmonary arterial hypertension; and F528 to treat chronic obstructive pulmonary disease. Gyre Therapeutics, Inc. was founded in 2002 and is headquartered in San Diego, California. Gyre Therapeutics, Inc. operates as a subsidiary of GNI USA, Inc.